All FAP patients carry inactivating mutations of the adenomatous polyposis coli (APC) tumour suppressor gene, and the gene is also mutated in 70–80% of sporadic colorectal adenomas and carcinomas (reviewed in Fearon, 2011). The gene discussed is APC; the disease is colorectal adenoma.